Colostral Proline-Rich Polypeptides - Immunoregulatory Properties and Prospects of Therapeutic Use in Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|7|4|323-333

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.7, Iss.4, 2010-06, pp. : 323-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypothalamic Proline-Rich Polypeptide is an Oxidative Burst Regulator

By Davtyan Tigran Manukyan Hayk Hakopyan Gagik Mkrtchyan Nana Avetisyan Samvel Galoyan Armen

Neurochemical Research, Vol. 30, Iss. 3, 2005-03 ,pp. : 297-309

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic approaches to Alzheimer's disease

By Klafki Hans-Wolfgang Staufenbiel Matthias Kornhuber Johannes Wiltfang Jens

Brain, Vol. 129, Iss. 11, 2006-11 ,pp. : 2840-2855

Oxford University Press

Access to resources Recommend Favorite

Hypothalamic Proline-Rich Polypeptide Protects Brain Neurons in Aluminum Neurotoxicosis

By Galoyan A. A. Shakhlamov V. A. Aghajanov M. I. Vahradyan H. G.

Neurochemical Research, Vol. 29, Iss. 7, 2004-07 ,pp. : 1349-1357

Springer Publishing Company

Access to resources Recommend Favorite

NO Chimeras as Therapeutic Agents in Alzheimer's Disease

Current Alzheimer Research, Vol. 3, Iss. 3, 2006-07 ,pp. : 237-245

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Use of Agonists of the Nuclear Receptor PPAR&ggr; in Alzheimer's Disease

Current Alzheimer Research, Vol. 4, Iss. 2, 2007-04 ,pp. : 159-164

Bentham Science Publishers

Access to resources Recommend Favorite